Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Differential Clinical Presentation, Intraoperative Management Strategies, and Surgical Outcomes After Endoscopic Endonasal Treatment of Cystic Sellar Masses.

Tafreshi AR, Du R, Rutkowski MJ, Donoho DA, Shiroishi MS, Liu CJ, Kim PE, Carmichael JD, Zada G.

World Neurosurg. 2019 Sep 7. pii: S1878-8750(19)32401-5. doi: 10.1016/j.wneu.2019.08.234. [Epub ahead of print]

PMID:
31505289
2.

Sporadic and Von-Hippel Lindau disease-associated spinal hemangioblastomas: institutional experience on their similarities and differences.

Yousef A, Rutkowski MJ, Yalcin CE, Eren OC, Caliskan I, Tihan T.

J Neurooncol. 2019 Jul;143(3):547-552. doi: 10.1007/s11060-019-03189-w. Epub 2019 May 14.

PMID:
31089924
3.

Medical versus surgical treatment of prolactinomas: an analysis of treatment outcomes.

Rutkowski MJ, Aghi MK.

Expert Rev Endocrinol Metab. 2018 Jan;13(1):25-33. doi: 10.1080/17446651.2018.1411798. Epub 2017 Dec 7. Review.

PMID:
30063440
4.

Before and after the veterans affairs cooperative program 468 study: Deep brain stimulator target selection for treatment of Parkinson's disease.

Southwell DG, Rutkowski MJ, San Luciano M, Racine C, Ostrem J, Starr PA, Larson PS.

Parkinsonism Relat Disord. 2018 Mar;48:40-44. doi: 10.1016/j.parkreldis.2017.12.013. Epub 2017 Dec 12.

PMID:
29249683
5.

Surgical intervention for pituitary apoplexy: an analysis of functional outcomes.

Rutkowski MJ, Kunwar S, Blevins L, Aghi MK.

J Neurosurg. 2018 Aug;129(2):417-424. doi: 10.3171/2017.2.JNS1784. Epub 2017 Sep 15.

PMID:
28946177
6.

Atypical pituitary adenoma: a clinicopathologic case series.

Rutkowski MJ, Alward RM, Chen R, Wagner J, Jahangiri A, Southwell DG, Kunwar S, Blevins L, Lee H, Aghi MK.

J Neurosurg. 2018 Apr;128(4):1058-1065. doi: 10.3171/2016.12.JNS162126. Epub 2017 Jun 9.

PMID:
28598278
7.

Surgical management of cerebral dural arteriovenous fistulae.

Rutkowski MJ, Jian B, Lawton MT.

Handb Clin Neurol. 2017;143:107-116. doi: 10.1016/B978-0-444-63640-9.00010-2. Review.

PMID:
28552132
8.

Metastatic clival chordoma: a case report of multiple extraneural metastases following resection and proton beam radiotherapy in a 5-year old boy.

Rutkowski MJ, Birk HS, Wood MD, Perry A, Nicolaides T, Ames CP, Gupta N.

J Neurosurg Pediatr. 2017 May;19(5):531-537. doi: 10.3171/2017.1.PEDS16549. Epub 2017 Mar 17.

9.

Pleomorphic Xanthoastrocytoma with Anaplastic Features: Retrospective Case Series.

Rutkowski MJ, Oh T, Niflioglu GG, Safaee M, Tihan T, Parsa AT.

World Neurosurg. 2016 Nov;95:368-374. doi: 10.1016/j.wneu.2016.07.068. Epub 2016 Jul 28.

PMID:
27476694
10.

Surgical Management of Intracranial Neuroenteric Cysts: The UCSF Experience.

Breshears JD, Rutkowski MJ, McDermott MW, Cha S, Tihan T, Theodosopoulos PV.

J Neurol Surg B Skull Base. 2015 Dec;76(6):475-9. doi: 10.1055/s-0035-1554906. Epub 2015 Jun 15.

11.

Meningiomas of the Anterior Clinoid Process: Is It Wise to Drill Out the Optic Canal?

Sughrue M, Kane A, Rutkowski MJ, Berger MS, McDermott MW.

Cureus. 2015 Sep 10;7(9):e321. doi: 10.7759/cureus.321.

12.

Approach to the postoperative patient with Cushing's disease.

Rutkowski MJ, Breshears JD, Kunwar S, Aghi MK, Blevins LS.

Pituitary. 2015 Apr;18(2):232-7. doi: 10.1007/s11102-015-0644-7. Review.

PMID:
25702104
13.

Update on the management of recurrent Cushing's disease.

Rutkowski MJ, Flanigan PM, Aghi MK.

Neurosurg Focus. 2015 Feb;38(2):E16. doi: 10.3171/2014.11.FOCUS14703. Review.

PMID:
25639318
14.

Survival outcomes of giant cell glioblastoma: institutional experience in the management of 20 patients.

Oh T, Rutkowski MJ, Safaee M, Sun MZ, Sayegh ET, Bloch O, Tihan T, Parsa AT.

J Clin Neurosci. 2014 Dec;21(12):2129-34. doi: 10.1016/j.jocn.2014.04.011. Epub 2014 Jul 16.

PMID:
25037316
15.

Effects of temporal lobectomy on consciousness-impairing and consciousness-sparing seizures in children.

Englot DJ, Rutkowski MJ, Ivan ME, Sun PP, Kuperman RA, Chang EF, Gupta N, Sullivan JE, Auguste KI.

Childs Nerv Syst. 2013 Oct;29(10):1915-22. doi: 10.1007/s00381-013-2168-7. Epub 2013 May 31.

16.

Gliomas promote immunosuppression through induction of B7-H1 expression in tumor-associated macrophages.

Bloch O, Crane CA, Kaur R, Safaee M, Rutkowski MJ, Parsa AT.

Clin Cancer Res. 2013 Jun 15;19(12):3165-75. doi: 10.1158/1078-0432.CCR-12-3314. Epub 2013 Apr 23.

17.

Multidisciplinary care of patients with brain tumors.

Huang T, Mueller S, Rutkowski MJ, Han SJ, Bloch O, Barani IJ, Parsa AT, Chang SM.

Surg Oncol Clin N Am. 2013 Apr;22(2):161-78. doi: 10.1016/j.soc.2012.12.011. Epub 2013 Jan 10. Review.

PMID:
23453330
18.

Modern surgical outcomes following surgery for sphenoid wing meningiomas.

Sughrue ME, Rutkowski MJ, Chen CJ, Shangari G, Kane AJ, Parsa AT, Berger MS, McDermott MW.

J Neurosurg. 2013 Jul;119(1):86-93. doi: 10.3171/2012.12.JNS11539. Epub 2013 Feb 22.

PMID:
23432379
19.

Supratentorial hemangioblastoma: clinical features, prognosis, and predictive value of location for von Hippel-Lindau disease.

Mills SA, Oh MC, Rutkowski MJ, Sughrue ME, Barani IJ, Parsa AT.

Neuro Oncol. 2012 Aug;14(8):1097-104. doi: 10.1093/neuonc/nos133. Epub 2012 Jun 21.

20.

The effect of the 2003 Consensus Reporting Standards on publications describing patients with vestibular schwannoma treated with stereotactic radiosurgery.

Han SJ, Oh MC, Sughrue ME, Rutkowski MJ, Aranda D, Barani IJ, Parsa AT.

J Clin Neurosci. 2012 Aug;19(8):1144-7. doi: 10.1016/j.jocn.2012.01.019. Epub 2012 Jun 7.

PMID:
22682649
21.

Evidence of ambiguous differentiation and mTOR pathway dysregulation in subependymal giant cell astrocytoma.

Barrows BD, Rutkowski MJ, Gültekın SH, Parsa AT, Tıhan T.

Turk Patoloji Derg. 2012;28(2):95-103. doi: 10.5146/tjpath.2012.01107.

22.

Reporting standard compliance in publications of vestibular schwannoma patients treated with microsurgery.

Han SJ, Oh MC, Sughrue ME, Aranda D, Rutkowski MJ, Parsa AT.

Otol Neurotol. 2012 Jun;33(4):648-50. doi: 10.1097/MAO.0b013e31824f998b.

PMID:
22525214
23.

Atypia predicting prognosis for intracranial extraventricular neurocytomas.

Kane AJ, Sughrue ME, Rutkowski MJ, Aranda D, Mills SA, Lehil M, Fang S, Parsa AT.

J Neurosurg. 2012 Feb;116(2):349-54. doi: 10.3171/2011.9.JNS10783. Epub 2011 Nov 4.

PMID:
22054208
24.

Management of recurrent intracranial hemangiopericytoma.

Rutkowski MJ, Bloch O, Jian BJ, Chen C, Sughrue ME, Tihan T, Barani IJ, Berger MS, McDermott MW, Parsa AT.

J Clin Neurosci. 2011 Nov;18(11):1500-4. doi: 10.1016/j.jocn.2011.04.009. Epub 2011 Sep 13.

PMID:
21917462
25.

Intracranial hemangiopericytoma: clinical experience and treatment considerations in a modern series of 40 adult patients.

Rutkowski MJ, Jian BJ, Bloch O, Chen C, Sughrue ME, Tihan T, Barani IJ, Berger MS, McDermott MW, Parsa AT.

Cancer. 2012 Mar 15;118(6):1628-36. doi: 10.1002/cncr.26411. Epub 2011 Aug 11.

26.

Contemporary management of pineoblastoma.

Tate MC, Rutkowski MJ, Parsa AT.

Neurosurg Clin N Am. 2011 Jul;22(3):409-12, ix. doi: 10.1016/j.nec.2011.05.001. Epub 2011 Jun 16. Review.

PMID:
21801990
27.

The long-term postsurgical prognosis of patients with pineoblastoma.

Tate M, Sughrue ME, Rutkowski MJ, Kane AJ, Aranda D, McClinton L, McClinton L, Barani IJ, Parsa AT.

Cancer. 2012 Jan 1;118(1):173-9. doi: 10.1002/cncr.26300. Epub 2011 Jun 29. Review.

28.

Clinical features and post-surgical outcome of patients with astroblastoma.

Sughrue ME, Choi J, Rutkowski MJ, Aranda D, Kane AJ, Barani IJ, Parsa AT.

J Clin Neurosci. 2011 Jun;18(6):750-4. doi: 10.1016/j.jocn.2010.11.007. Epub 2011 Apr 19. Review.

PMID:
21507653
29.

Clinical and surgical considerations for cerebellopontine angle meningiomas.

Kane AJ, Sughrue ME, Rutkowski MJ, Berger MS, McDermott MW, Parsa AT.

J Clin Neurosci. 2011 Jun;18(6):755-9. doi: 10.1016/j.jocn.2010.09.023. Epub 2011 Apr 19.

PMID:
21507650
30.

Epidermal growth factor module-containing mucin-like receptor 2 is a newly identified adhesion G protein-coupled receptor associated with poor overall survival and an invasive phenotype in glioblastoma.

Rutkowski MJ, Sughrue ME, Kane AJ, Kim JM, Bloch O, Parsa AT.

J Neurooncol. 2011 Nov;105(2):165-71. doi: 10.1007/s11060-011-0576-7. Epub 2011 Apr 19.

PMID:
21503828
31.

Anatomic location is a risk factor for atypical and malignant meningiomas.

Kane AJ, Sughrue ME, Rutkowski MJ, Shangari G, Fang S, McDermott MW, Berger MS, Parsa AT.

Cancer. 2011 Mar 15;117(6):1272-8. doi: 10.1002/cncr.25591. Epub 2010 Nov 8.

32.

Incidence, risk factors, and outcome of venous infarction after meningioma surgery in 705 patients.

Sughrue ME, Rutkowski MJ, Shangari G, Fang S, Parsa AT, Berger MS, McDermott MW.

J Clin Neurosci. 2011 May;18(5):628-32. doi: 10.1016/j.jocn.2010.10.001. Epub 2011 Feb 23.

PMID:
21349725
33.

Extent of resection and the long-term durability of vestibular schwannoma surgery.

Sughrue ME, Kaur R, Rutkowski MJ, Kane AJ, Kaur G, Yang I, Pitts LH, Parsa AT.

J Neurosurg. 2011 May;114(5):1218-23. doi: 10.3171/2010.11.JNS10257. Epub 2011 Jan 21.

PMID:
21250800
34.

Implications of cystic features in vestibular schwannomas of patients undergoing microsurgical resection.

Jian BJ, Sughrue ME, Kaur R, Rutkowski MJ, Kane AJ, Kaur G, Yang I, Pitts LH, Parsa AT.

Neurosurgery. 2011 Apr;68(4):874-80; discussion 879-80. doi: 10.1227/NEU.0b013e318208f614.

PMID:
21221029
35.

A critical evaluation of vestibular schwannoma surgery for patients younger than 40 years of age.

Sughrue ME, Kaur R, Rutkowski MJ, Kane AJ, Yang I, Pitts LH, Parsa AT.

Neurosurgery. 2010 Dec;67(6):1646-53; discussion 1653-4. doi: 10.1227/NEU.0b013e3181f8d3d3.

PMID:
21107195
36.

Preservation of facial nerve function after resection of vestibular schwannoma.

Sughrue ME, Yang I, Rutkowski MJ, Aranda D, Parsa AT.

Br J Neurosurg. 2010 Dec;24(6):666-71. doi: 10.3109/02688697.2010.520761. Review.

PMID:
21070151
37.

Results with judicious modern neurosurgical management of parasagittal and falcine meningiomas. Clinical article.

Sughrue ME, Rutkowski MJ, Shangari G, Parsa AT, Berger MS, McDermott MW.

J Neurosurg. 2011 Mar;114(3):731-7. doi: 10.3171/2010.9.JNS10646. Epub 2010 Oct 15.

PMID:
20950085
38.

The molecular pathology of central neurocytomas.

Kane AJ, Sughrue ME, Rutkowski MJ, Tihan T, Parsa AT.

J Clin Neurosci. 2011 Jan;18(1):1-6. doi: 10.1016/j.jocn.2010.06.004. Epub 2010 Sep 29. Review.

PMID:
20884210
39.

Cancer and the complement cascade.

Rutkowski MJ, Sughrue ME, Kane AJ, Mills SA, Parsa AT.

Mol Cancer Res. 2010 Nov;8(11):1453-65. doi: 10.1158/1541-7786.MCR-10-0225. Epub 2010 Sep 24. Review.

40.

Human glioma demonstrates cell line specific results with ATP-based chemiluminescent cellular proliferation assays.

Sughrue ME, Rutkowski MJ, Kane AJ, Parsa AT.

J Clin Neurosci. 2010 Dec;17(12):1573-7. doi: 10.1016/j.jocn.2010.05.007. Epub 2010 Sep 9.

41.

EMR-3: a potential mediator of invasive phenotypic variation in glioblastoma and novel therapeutic target.

Kane AJ, Sughrue ME, Rutkowski MJ, Phillips JJ, Parsa AT.

Neuroreport. 2010 Nov 17;21(16):1018-22. doi: 10.1097/WNR.0b013e32833f19f2.

42.

Factors associated with preservation of facial nerve function after surgical resection of vestibular schwannoma.

Bloch O, Sughrue ME, Kaur R, Kane AJ, Rutkowski MJ, Kaur G, Yang I, Pitts LH, Parsa AT.

J Neurooncol. 2011 Apr;102(2):281-6. doi: 10.1007/s11060-010-0315-5. Epub 2010 Aug 6.

43.

Risk factors for the development of serious medical complications after resection of meningiomas. Clinical article.

Sughrue ME, Rutkowski MJ, Shangari G, Chang HQ, Parsa AT, Berger MS, McDermott MW.

J Neurosurg. 2011 Mar;114(3):697-704. doi: 10.3171/2010.6.JNS091974. Epub 2010 Jul 23.

PMID:
20653395
44.

Postoperative seizures following the resection of convexity meningiomas: are prophylactic anticonvulsants indicated? Clinical article.

Sughrue ME, Rutkowski MJ, Chang EF, Shangari G, Kane AJ, McDermott MW, Berger MS, Parsa AT.

J Neurosurg. 2011 Mar;114(3):705-9. doi: 10.3171/2010.5.JNS091972. Epub 2010 Jun 25.

PMID:
20578801
45.

Intratumoral hemorrhage and fibrosis in vestibular schwannoma: a possible mechanism for hearing loss.

Sughrue ME, Kaur R, Kane AJ, Rutkowski MJ, Yang I, Pitts LH, Tihan T, Parsa AT.

J Neurosurg. 2011 Feb;114(2):386-93. doi: 10.3171/2010.5.JNS10256. Epub 2010 Jun 18.

PMID:
20560722
46.

The complement cascade as a mediator of tissue growth and regeneration.

Rutkowski MJ, Sughrue ME, Kane AJ, Ahn BJ, Fang S, Parsa AT.

Inflamm Res. 2010 Nov;59(11):897-905. doi: 10.1007/s00011-010-0220-6. Epub 2010 Jun 2. Review.

47.

A prospective study of hearing preservation in untreated vestibular schwannomas.

Sughrue ME, Kane AJ, Kaur R, Barry JJ, Rutkowski MJ, Pitts LH, Cheung SW, Parsa AT.

J Neurosurg. 2011 Feb;114(2):381-5. doi: 10.3171/2010.4.JNS091962. Epub 2010 May 21.

PMID:
20486891
48.

The value of intraoperative facial nerve electromyography in predicting facial nerve function after vestibular schwannoma surgery.

Sughrue ME, Kaur R, Kane AJ, Rutkowski MJ, Kaur G, Yang I, Pitts LH, Parsa AT.

J Clin Neurosci. 2010 Jul;17(7):849-52. doi: 10.1016/j.jocn.2010.02.003. Epub 2010 May 14.

PMID:
20471836
49.

Factors influencing overall survival rates for patients with pineocytoma.

Clark AJ, Sughrue ME, Ivan ME, Aranda D, Rutkowski MJ, Kane AJ, Chang S, Parsa AT.

J Neurooncol. 2010 Nov;100(2):255-60. doi: 10.1007/s11060-010-0189-6. Epub 2010 May 12.

50.

Factors affecting outcome following treatment of patients with cavernous sinus meningiomas.

Sughrue ME, Rutkowski MJ, Aranda D, Barani IJ, McDermott MW, Parsa AT.

J Neurosurg. 2010 Nov;113(5):1087-92. doi: 10.3171/2010.3.JNS091807. Epub 2010 May 7.

PMID:
20450274

Supplemental Content

Loading ...
Support Center